Symbol | Exchange | Currency |
|---|
It's been a feast for bulls operating on an hourly timeframe, as prah has now gone up 8 of the past 10 hours.The post PRA Health Sciences Inc (PRAH): Price Now Near $174.55; Daily...
RALEIGH, N.C., April 21, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ:PRAH) announced today the expansion of its pharmacovigilance solution to offer full post-marketing...
Shares of Vericel (NASDAQ:VCEL) Corporation VCEL rose 4.4% after the company reported fourth-quarter 2020 adjusted earnings per share of $0.25, beating the Zacks Consensus Estimate...
PRA Health Sciences (NASDAQ:PRAH), Inc. PRAH and The Leukemia & Lymphoma Society (LLS) recently collaborated to introduce a first-of-its-kind global clinical master trial in...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Sell | Strong Sell | Neutral | Strong Buy |
| Technical Indicators | Sell | Strong Sell | Strong Sell | Strong Sell | Strong Buy |
| Summary | Sell | Strong Sell | Strong Sell | Sell | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 331.26 | 332.83 | 328.93 | -1.20 | -0.36% | 13.59M | NASDAQ | |||
| 2,430.20 | 2,441.72 | 2,418.96 | -4.93 | -0.20% | 1.10M | NASDAQ | |||
| 13.79 | 14.26 | 13.67 | +0.03 | +0.22% | 524.25K | NYSE | |||
| 5.89 | 5.96 | 5.759 | +0.070 | +1.20% | 864.64K | NASDAQ | |||
| 9.39 | 9.45 | 8.84 | -0.2100 | -2.19% | 8.34K | OTC Markets | |||
| 8.16 | 8.19 | 8.15 | +0.06 | +0.74% | 128.52K | NYSE | |||
| 211.64 | 213.46 | 211.00 | -1.43 | -0.67% | 12.28M | NYSE | |||
| 30.08 | 30.20 | 29.85 | +0.11 | +0.37% | 11.42M | NYSE | |||
| 24.67 | 24.71 | 24.03 | +0.53 | +2.20% | 33.11M | NYSE | |||
| 111.00 | 111.84 | 110.06 | +1.00 | +0.91% | 230.34K | NYSE | |||
| 23.92 | 27.92 | 21.58 | +3.920 | +19.60% | 3.02M | NASDAQ | |||
| 45.68 | 46.26 | 42.76 | +2.92 | +6.83% | 85.73M | NYSE | |||
| 263.07 | 264.00 | 260.86 | +1.00 | +0.38% | 492.94K | NASDAQ | |||
| 11.35 | 11.35 | 11.35 | 0.00 | 0.00% | 0.00 | NASDAQ | |||
| 2,513.93 | 2,526.99 | 2,498.29 | -7.67 | -0.30% | 1.26M | NASDAQ |
PRA Health Sciences, Inc. is a contract research organization. The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company offers therapeutic services in areas of pharmaceutical development, including oncology, central nervous system, inflammation and infectious diseases. Its services include data management, statistical analysis, clinical trial management, and regulatory and drug development consulting. It provides its clients with clinical development service offerings, which includes both traditional, project-based Phase I through Phase IV services, as well as embedded and functional outsourcing services. As of December 31, 2016, its clinical development platform included approximately 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East. The Company's service offerings include product registration, strategic solutions and early development services.